The European Commission has granted marketing authorization for Kostaive (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, ...

Global biotechnology leader CSL and sa-mRNA pioneer Arcturus Therapeutics today announced that the European Commission has granted marketing authorization for KOSTAIVE® (ARCT-154), a self-amplifying ...

CENTEGIX, the industry leader and most used wearable panic button provider, today announced significant business milestones and momentum from 2024. CENTEGIX now protects 14 million individuals across ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public skepticism (35% comfortable with technology) and challenges translating ...

Most of the six million people who experience it each year also want to avoid some of its other more uncomfortable symptoms. These include increased sensitivity to light, an acute burning ...

“It is with sheer luck that the Arcturus encountered them shortly afterwards ... which should never have occurred when these four people who were part of the small boat migration found ...

HC Wainwright reaffirmed a “buy” rating and issued a $63.00 price objective on shares of Arcturus Therapeutics in a research note on Monday, January 13th. Cantor Fitzgerald reiterated an ...